Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $54.75 and last traded at $54.70, with a volume of 2168 shares changing hands. The stock had previously closed at $54.06.
Analysts Set New Price Targets
Separately, Royal Bank Of Canada raised Sandoz Group from a "hold" rating to a "moderate buy" rating in a research report on Friday, May 2nd.
Get Our Latest Stock Analysis on SDZNY
Sandoz Group Stock Performance
The company has a 50-day moving average of $50.17 and a 200-day moving average of $45.69. The company has a current ratio of 1.24, a quick ratio of 0.79 and a debt-to-equity ratio of 0.57.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Recommended Stories
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
